InnoCare Pharma Limited
INCPF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $6 | $28 | $43 | $38 |
| - Cash | $1 | $7 | $7 | $6 |
| + Debt | $0 | $2 | $2 | $1 |
| Enterprise Value | $5 | $23 | $37 | $33 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -84.6% | -8.2% | 22.3% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 87.4% | 88.4% | 90.5% | 87% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -4.9% | -25.3% | -0.9% | -39% |
| Net Income | -$0 | -$0 | $0 | -$0 |
| % Margin | -8.9% | -13.7% | 4.7% | -53% |
| EPS Diluted | -0.003 | -0.04 | 0.01 | -0.1 |
| % Growth | 93.2% | -496% | 110% | – |
| Operating Cash Flow | -$0 | -$0 | $0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | $0 | -$0 |